TITLE

A tincture of hepcidin cures all: the potential for hepcidin therapeutics

AUTHOR(S)
Bartnikas, Thomas B.; Fleming, Mark D.
PUB. DATE
December 2010
SOURCE
Journal of Clinical Investigation;Dec2010, Vol. 120 Issue 12, p4187
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Iron overload as a result of blood transfusions and excessive intestinal iron absorption can be a complication of chronic anemias such as β-thalassemia. Inappropriately low levels of hepcidin, a negative regulator of iron absorption and recycling, underlie the pathophysiology of the intestinal hyperabsorption. In this issue of the JCI, Gardenghi et al. demonstrate that increasing hepcidin expression to induce iron deficiency in murine β-thalassemia not only mitigates the iron overload, but also the severity of the anemia. These data illustrate the therapeutic potential of modulating hepcidin expression in diseases associated with altered iron metabolism.
ACCESSION #
55792489

 

Related Articles

  • Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. Gardenghi, Sara; Ramos, Pedro; Marongiu, Maria Franca; Melchiori, Luca; Breda, Laura; Guy, Ella; Muirhead, Kristen; Rao, Niva; Roy, Cindy N.; Andrews, Nancy C.; Nemeth, Elizabeta; Follenzi, Antonia; Xiuli An; Mohandas, Narla; Ginzburg, Yelena; Rachmilewitz, Eliezer A.; Giardina, Patricia J.; Grady, Robert W.; Rivella, Stefano; An, Xiuli // Journal of Clinical Investigation;Dec2010, Vol. 120 Issue 12, p4466 

    Excessive iron absorption is one of the main features of β-thalassemia and can lead to severe morbidity and mortality. Serial analyses of β-thalassemic mice indicate that while hemoglobin levels decrease over time, the concentration of iron in the liver, spleen, and kidneys markedly...

  • Iron metabolism in heterozygotes for hemoglobin E (HbE), α-thalassemia 1, or β-thalassemia and in compound heterozygotes for HbE/βthalassemia.  // American Journal of Clinical Nutrition;Oct2008, Vol. 88 Issue 4, p1026 

    The article presents a study of the potential difference of iron absorption or utilization in women heterozygous for β-thalassemia, α-thalassemia 1 or hemoglobin HbE/β from the control subjects and compound HbE/β-thalassemia heterozygotes Thai women. Results showed that dietary...

  • New Pharmacological Concepts for the Treatment of Iron Overload Disorders. Mair, Sabine M.; Weiss, Guenter // Current Medicinal Chemistry;Feb2009, Vol. 16 Issue 5, p576 

    Imbalances of iron homeostasis cause frequent clinical syndromes. Iron deficiency affects almost 25% of the global population and approximately one billion people suffer from iron deficiency anaemia. Moreover, the anaemia of chronic disease, which develops primarily in subjects suffering from...

  • Ferroportin and Erythroid Cells: An Update. Cianetti, Luciano; Gabbianelli, Marco; Sposi, Nadia Maria // Advances in Hematology;2010, Vol. 2010, p1 

    In recent years there have been major advances in our knowledge of the regulation of iron metabolism that have had implications for understanding the pathophysiology of some human disorders like beta-thalassemia and other iron overload diseases. However, little is known about the relationship...

  • Physiopathology of Bone Modifications in β-Thalassemia. Perisano, Carlo; Marzetti, Emanuele; Silvia Spinelli, Maria; Anna Maria Calla, Cinzia; Graci, Calogero; Maccauro, Giulio // Anemia (20901267);2012, p1 

    β-thalassemia major (βTM) or Cooley anemia is characterized by significantly reduced or absent synthesis of β-globin chains, which induces important pathologic consequences including hemolytic anemia, altered erythropoiesis, and bone marrow overstimulation. The pathogenesis of bone...

  • Subclinical autonomic dysfunction in patients with beta-thalassemia. Stamboulis, Elefterios; Vlachou, Nikoleta; Voumvourakis, Konstantinos; Andrikopoulou, Athina; Arvaniti, Chrisa; Tsivgoulis, Athanasios; Athanasiadis, Dimitrios; Tsiodras, Sotirios; Tentolouris, Nikolaos; Triantafyllidi, Heleni; Drossou-Servou, Marouso; Loutradi-Anagnostou, Aphrodite; Tsivgoulis, Georgios // Clinical Autonomic Research;Jun2012, Vol. 22 Issue 3, p147 

    We electrophysiologically evaluated the autonomic function (AF) in a consecutive series of patients with beta-thalassemia and in normal individuals. Six quantitative autonomic function tests (AFTs) were used: tilt test, hand grip test and sympathetic skin response for sympathetic function; R-R...

  • Identification of erythroferrone as an erythroid regulator of iron metabolism. Kautz, Léon; Jung, Grace; Valore, Erika V; Rivella, Stefano; Nemeth, Elizabeta; Ganz, Tomas // Nature Genetics;Jul2014, Vol. 46 Issue 7, p678 

    Recovery from blood loss requires a greatly enhanced supply of iron to support expanded erythropoiesis. After hemorrhage, suppression of the iron-regulatory hormone hepcidin allows increased iron absorption and mobilization from stores. We identified a new hormone, erythroferrone (ERFE), that...

  • Transferrin therapy ameliorates disease in β-thalassemic mice. Huihui Li; Rybicki, Anne C.; Suzuka, Sandra M.; von Bonsdorff, Leni; Breuer, William; Hall, Charles B.; Cabantchik, Z. Ioav; Bouhassira, Eric E.; Fabry, Mary E.; Ginzburg, Yelena Z. // Nature Medicine;Feb2010, Vol. 16 Issue 2, p177 

    Individuals with β-thalassemia develop progressive systemic iron overload, resulting in high morbidity and mortality. These complications are caused by labile plasma iron, which is taken up by parenchymal cells in a dysregulated manner; in contrast, erythropoiesis depends on transferrin-bound...

  • Lifetime Cost-Utility Analyses of Deferasirox in Beta-Thalassaemia Patients with Chronic Iron Overload. Karnon, Jonathan; Tolley, Keith; Vieira, Joao; Chandiwana, David // Clinical Drug Investigation;2012, Vol. 32 Issue 12, p805 

    Background and objectives Regular blood transfusions for beta-thalassaemia patients lead to the accumulation of iron deposits in the body. In order to remove such deposits, iron chelation therapy is required. Subcutaneously administered deferoxamine has been the gold standard chelation therapy...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics